nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—ABCB1—Methylprednisolone—multiple sclerosis	0.0378	0.124	CbGbCtD
Bromocriptine—CYP3A4—Fingolimod—multiple sclerosis	0.0351	0.115	CbGbCtD
Bromocriptine—HTR1B—trigeminal nucleus—multiple sclerosis	0.035	0.15	CbGeAlD
Bromocriptine—HTR1D—trigeminal nucleus—multiple sclerosis	0.0339	0.145	CbGeAlD
Bromocriptine—ABCB1—Mitoxantrone—multiple sclerosis	0.0276	0.0901	CbGbCtD
Bromocriptine—ABCB1—Betamethasone—multiple sclerosis	0.0246	0.0803	CbGbCtD
Bromocriptine—ABCB1—Prednisolone—multiple sclerosis	0.0242	0.0793	CbGbCtD
Bromocriptine—ABCB1—Prednisone—multiple sclerosis	0.0229	0.0749	CbGbCtD
Bromocriptine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0226	0.074	CbGbCtD
Bromocriptine—HTR1D—meninx—multiple sclerosis	0.0225	0.0962	CbGeAlD
Bromocriptine—CYP3A4—Triamcinolone—multiple sclerosis	0.0172	0.0561	CbGbCtD
Bromocriptine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0169	0.072	CbGeAlD
Bromocriptine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0165	0.054	CbGbCtD
Bromocriptine—CYP3A4—Betamethasone—multiple sclerosis	0.0147	0.0481	CbGbCtD
Bromocriptine—CYP3A4—Prednisolone—multiple sclerosis	0.0145	0.0475	CbGbCtD
Bromocriptine—ABCB1—Dexamethasone—multiple sclerosis	0.0143	0.0467	CbGbCtD
Bromocriptine—CYP3A4—Prednisone—multiple sclerosis	0.0137	0.0448	CbGbCtD
Bromocriptine—ABCB1—Methotrexate—multiple sclerosis	0.0115	0.0376	CbGbCtD
Bromocriptine—HTR1B—trigeminal nerve—multiple sclerosis	0.0092	0.0393	CbGeAlD
Bromocriptine—HTR1D—trigeminal nerve—multiple sclerosis	0.00891	0.0381	CbGeAlD
Bromocriptine—CYP3A4—Dexamethasone—multiple sclerosis	0.00856	0.028	CbGbCtD
Bromocriptine—HTR7—pons—multiple sclerosis	0.005	0.0213	CbGeAlD
Bromocriptine—HTR2A—trigeminal nerve—multiple sclerosis	0.00443	0.0189	CbGeAlD
Bromocriptine—DRD1—nerve—multiple sclerosis	0.00415	0.0177	CbGeAlD
Bromocriptine—HTR7—peripheral nervous system—multiple sclerosis	0.00332	0.0142	CbGeAlD
Bromocriptine—HTR2A—pons—multiple sclerosis	0.00312	0.0133	CbGeAlD
Bromocriptine—HTR7—nerve—multiple sclerosis	0.00259	0.0111	CbGeAlD
Bromocriptine—DRD2—nerve—multiple sclerosis	0.00245	0.0105	CbGeAlD
Bromocriptine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00244	0.0104	CbGeAlD
Bromocriptine—HTR2A—pineal body—multiple sclerosis	0.00222	0.0095	CbGeAlD
Bromocriptine—HTR2A—peripheral nervous system—multiple sclerosis	0.00207	0.00886	CbGeAlD
Bromocriptine—DRD1—brainstem—multiple sclerosis	0.00178	0.00761	CbGeAlD
Bromocriptine—HTR2A—nerve—multiple sclerosis	0.00162	0.0069	CbGeAlD
Bromocriptine—HTR1B—brainstem—multiple sclerosis	0.00144	0.00616	CbGeAlD
Bromocriptine—DRD4—brain—multiple sclerosis	0.00142	0.00605	CbGeAlD
Bromocriptine—HTR1D—brainstem—multiple sclerosis	0.0014	0.00597	CbGeAlD
Bromocriptine—HTR2C—brainstem—multiple sclerosis	0.00138	0.00591	CbGeAlD
Bromocriptine—DRD3—nervous system—multiple sclerosis	0.0013	0.00557	CbGeAlD
Bromocriptine—DRD3—central nervous system—multiple sclerosis	0.00125	0.00536	CbGeAlD
Bromocriptine—HTR6—nervous system—multiple sclerosis	0.00125	0.00536	CbGeAlD
Bromocriptine—DRD5—nervous system—multiple sclerosis	0.00122	0.00522	CbGeAlD
Bromocriptine—HTR6—central nervous system—multiple sclerosis	0.00121	0.00516	CbGeAlD
Bromocriptine—DRD5—central nervous system—multiple sclerosis	0.00118	0.00502	CbGeAlD
Bromocriptine—HTR1A—brainstem—multiple sclerosis	0.00116	0.00497	CbGeAlD
Bromocriptine—DRD1—midbrain—multiple sclerosis	0.00113	0.00485	CbGeAlD
Bromocriptine—HTR7—brainstem—multiple sclerosis	0.00111	0.00475	CbGeAlD
Bromocriptine—ADRA1A—brainstem—multiple sclerosis	0.00107	0.00458	CbGeAlD
Bromocriptine—DRD2—brainstem—multiple sclerosis	0.00105	0.00449	CbGeAlD
Bromocriptine—DRD2—retina—multiple sclerosis	0.00101	0.00434	CbGeAlD
Bromocriptine—ADRA1B—nervous system—multiple sclerosis	0.001	0.00428	CbGeAlD
Bromocriptine—DRD3—brain—multiple sclerosis	0.000996	0.00425	CbGeAlD
Bromocriptine—ADRA1D—nervous system—multiple sclerosis	0.000979	0.00418	CbGeAlD
Bromocriptine—HTR2C—medulla oblongata—multiple sclerosis	0.000964	0.00412	CbGeAlD
Bromocriptine—ADRA1B—central nervous system—multiple sclerosis	0.000964	0.00412	CbGeAlD
Bromocriptine—HTR6—brain—multiple sclerosis	0.000959	0.00409	CbGeAlD
Bromocriptine—ADRA1D—central nervous system—multiple sclerosis	0.000943	0.00403	CbGeAlD
Bromocriptine—DRD5—brain—multiple sclerosis	0.000933	0.00399	CbGeAlD
Bromocriptine—DRD1—nervous system—multiple sclerosis	0.000933	0.00399	CbGeAlD
Bromocriptine—HTR1B—midbrain—multiple sclerosis	0.000919	0.00393	CbGeAlD
Bromocriptine—DRD1—central nervous system—multiple sclerosis	0.000898	0.00384	CbGeAlD
Bromocriptine—HTR1B—spinal cord—multiple sclerosis	0.000897	0.00383	CbGeAlD
Bromocriptine—HTR1D—midbrain—multiple sclerosis	0.00089	0.0038	CbGeAlD
Bromocriptine—HTR2C—midbrain—multiple sclerosis	0.000881	0.00377	CbGeAlD
Bromocriptine—HTR2C—spinal cord—multiple sclerosis	0.00086	0.00367	CbGeAlD
Bromocriptine—HTR7—medulla oblongata—multiple sclerosis	0.000776	0.00331	CbGeAlD
Bromocriptine—ADRA1B—brain—multiple sclerosis	0.000765	0.00327	CbGeAlD
Bromocriptine—HTR1B—nervous system—multiple sclerosis	0.000756	0.00323	CbGeAlD
Bromocriptine—ADRA1D—brain—multiple sclerosis	0.000748	0.0032	CbGeAlD
Bromocriptine—HTR1A—midbrain—multiple sclerosis	0.000742	0.00317	CbGeAlD
Bromocriptine—HTR1D—nervous system—multiple sclerosis	0.000732	0.00313	CbGeAlD
Bromocriptine—HTR1B—central nervous system—multiple sclerosis	0.000728	0.00311	CbGeAlD
Bromocriptine—HTR2C—nervous system—multiple sclerosis	0.000725	0.0031	CbGeAlD
Bromocriptine—HTR1A—spinal cord—multiple sclerosis	0.000724	0.00309	CbGeAlD
Bromocriptine—ADRA2C—medulla oblongata—multiple sclerosis	0.000713	0.00305	CbGeAlD
Bromocriptine—DRD1—brain—multiple sclerosis	0.000713	0.00305	CbGeAlD
Bromocriptine—ADRB1—nervous system—multiple sclerosis	0.000711	0.00304	CbGeAlD
Bromocriptine—HTR7—midbrain—multiple sclerosis	0.000709	0.00303	CbGeAlD
Bromocriptine—HTR1D—central nervous system—multiple sclerosis	0.000705	0.00301	CbGeAlD
Bromocriptine—HTR2C—central nervous system—multiple sclerosis	0.000698	0.00298	CbGeAlD
Bromocriptine—HTR2A—brainstem—multiple sclerosis	0.000694	0.00296	CbGeAlD
Bromocriptine—HTR7—spinal cord—multiple sclerosis	0.000692	0.00296	CbGeAlD
Bromocriptine—ADRB1—central nervous system—multiple sclerosis	0.000685	0.00292	CbGeAlD
Bromocriptine—HTR2B—nervous system—multiple sclerosis	0.000681	0.00291	CbGeAlD
Bromocriptine—DRD2—midbrain—multiple sclerosis	0.00067	0.00286	CbGeAlD
Bromocriptine—HTR2A—retina—multiple sclerosis	0.000669	0.00286	CbGeAlD
Bromocriptine—HTR2B—central nervous system—multiple sclerosis	0.000655	0.0028	CbGeAlD
Bromocriptine—ADRA2C—midbrain—multiple sclerosis	0.000652	0.00278	CbGeAlD
Bromocriptine—ADRA2C—spinal cord—multiple sclerosis	0.000636	0.00272	CbGeAlD
Bromocriptine—HTR1A—nervous system—multiple sclerosis	0.00061	0.00261	CbGeAlD
Bromocriptine—HTR1A—central nervous system—multiple sclerosis	0.000587	0.00251	CbGeAlD
Bromocriptine—HTR7—nervous system—multiple sclerosis	0.000583	0.00249	CbGeAlD
Bromocriptine—HTR1B—brain—multiple sclerosis	0.000578	0.00247	CbGeAlD
Bromocriptine—HTR1A—cerebellum—multiple sclerosis	0.000574	0.00245	CbGeAlD
Bromocriptine—ADRA2A—medulla oblongata—multiple sclerosis	0.000569	0.00243	CbGeAlD
Bromocriptine—ADRA1A—nervous system—multiple sclerosis	0.000562	0.0024	CbGeAlD
Bromocriptine—HTR7—central nervous system—multiple sclerosis	0.000561	0.0024	CbGeAlD
Bromocriptine—HTR1D—brain—multiple sclerosis	0.000559	0.00239	CbGeAlD
Bromocriptine—HTR2C—brain—multiple sclerosis	0.000554	0.00237	CbGeAlD
Bromocriptine—DRD2—nervous system—multiple sclerosis	0.000551	0.00235	CbGeAlD
Bromocriptine—HTR7—cerebellum—multiple sclerosis	0.000549	0.00234	CbGeAlD
Bromocriptine—ADRB1—brain—multiple sclerosis	0.000544	0.00232	CbGeAlD
Bromocriptine—ADRA1A—central nervous system—multiple sclerosis	0.000541	0.00231	CbGeAlD
Bromocriptine—ADRA2C—nervous system—multiple sclerosis	0.000536	0.00229	CbGeAlD
Bromocriptine—DRD2—central nervous system—multiple sclerosis	0.000531	0.00227	CbGeAlD
Bromocriptine—ADRA1A—cerebellum—multiple sclerosis	0.000529	0.00226	CbGeAlD
Bromocriptine—HTR2B—brain—multiple sclerosis	0.00052	0.00222	CbGeAlD
Bromocriptine—ADRA2A—midbrain—multiple sclerosis	0.00052	0.00222	CbGeAlD
Bromocriptine—DRD2—cerebellum—multiple sclerosis	0.000519	0.00222	CbGeAlD
Bromocriptine—ADRA2C—central nervous system—multiple sclerosis	0.000516	0.0022	CbGeAlD
Bromocriptine—ADRA2A—spinal cord—multiple sclerosis	0.000507	0.00217	CbGeAlD
Bromocriptine—ADRA2C—cerebellum—multiple sclerosis	0.000504	0.00215	CbGeAlD
Bromocriptine—HTR2A—medulla oblongata—multiple sclerosis	0.000484	0.00207	CbGeAlD
Bromocriptine—HTR1A—brain—multiple sclerosis	0.000466	0.00199	CbGeAlD
Bromocriptine—HTR7—brain—multiple sclerosis	0.000446	0.0019	CbGeAlD
Bromocriptine—HTR2A—midbrain—multiple sclerosis	0.000442	0.00189	CbGeAlD
Bromocriptine—ABCB1—retina—multiple sclerosis	0.000439	0.00187	CbGeAlD
Bromocriptine—HTR2A—spinal cord—multiple sclerosis	0.000431	0.00184	CbGeAlD
Bromocriptine—ADRA1A—brain—multiple sclerosis	0.00043	0.00184	CbGeAlD
Bromocriptine—ADRA2A—nervous system—multiple sclerosis	0.000428	0.00183	CbGeAlD
Bromocriptine—DRD2—brain—multiple sclerosis	0.000421	0.0018	CbGeAlD
Bromocriptine—ADRA2A—central nervous system—multiple sclerosis	0.000412	0.00176	CbGeAlD
Bromocriptine—ADRA2C—brain—multiple sclerosis	0.00041	0.00175	CbGeAlD
Bromocriptine—ADRA2A—cerebellum—multiple sclerosis	0.000402	0.00172	CbGeAlD
Bromocriptine—HTR2A—nervous system—multiple sclerosis	0.000364	0.00155	CbGeAlD
Bromocriptine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000358	0.00136	CcSEcCtD
Bromocriptine—Somnolence—Mitoxantrone—multiple sclerosis	0.000357	0.00136	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000355	0.00135	CcSEcCtD
Bromocriptine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000353	0.00134	CcSEcCtD
Bromocriptine—Angiopathy—Dexamethasone—multiple sclerosis	0.000351	0.00133	CcSEcCtD
Bromocriptine—Angiopathy—Betamethasone—multiple sclerosis	0.000351	0.00133	CcSEcCtD
Bromocriptine—HTR2A—central nervous system—multiple sclerosis	0.00035	0.0015	CbGeAlD
Bromocriptine—Convulsion—Prednisolone—multiple sclerosis	0.00035	0.00133	CcSEcCtD
Bromocriptine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000349	0.00133	CcSEcCtD
Bromocriptine—Hypertension—Prednisolone—multiple sclerosis	0.000348	0.00132	CcSEcCtD
Bromocriptine—Fatigue—Mitoxantrone—multiple sclerosis	0.000346	0.00132	CcSEcCtD
Bromocriptine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000346	0.00131	CcSEcCtD
Bromocriptine—Arrhythmia—Betamethasone—multiple sclerosis	0.000346	0.00131	CcSEcCtD
Bromocriptine—Constipation—Mitoxantrone—multiple sclerosis	0.000343	0.0013	CcSEcCtD
Bromocriptine—Bradycardia—Prednisone—multiple sclerosis	0.000343	0.0013	CcSEcCtD
Bromocriptine—HTR2A—cerebellum—multiple sclerosis	0.000342	0.00146	CbGeAlD
Bromocriptine—Alopecia—Dexamethasone—multiple sclerosis	0.000342	0.0013	CcSEcCtD
Bromocriptine—Alopecia—Betamethasone—multiple sclerosis	0.000342	0.0013	CcSEcCtD
Bromocriptine—Diarrhoea—Azathioprine—multiple sclerosis	0.00034	0.00129	CcSEcCtD
Bromocriptine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000337	0.00128	CcSEcCtD
Bromocriptine—CYP3A4—nervous system—multiple sclerosis	0.000337	0.00144	CbGeAlD
Bromocriptine—Hallucination—Prednisone—multiple sclerosis	0.000335	0.00127	CcSEcCtD
Bromocriptine—Vertigo—Triamcinolone—multiple sclerosis	0.000333	0.00127	CcSEcCtD
Bromocriptine—Syncope—Triamcinolone—multiple sclerosis	0.000333	0.00126	CcSEcCtD
Bromocriptine—Vertigo—Methylprednisolone—multiple sclerosis	0.000333	0.00126	CcSEcCtD
Bromocriptine—Syncope—Methylprednisolone—multiple sclerosis	0.000332	0.00126	CcSEcCtD
Bromocriptine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000331	0.00126	CcSEcCtD
Bromocriptine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000331	0.00126	CcSEcCtD
Bromocriptine—Oedema—Prednisolone—multiple sclerosis	0.000329	0.00125	CcSEcCtD
Bromocriptine—Dizziness—Azathioprine—multiple sclerosis	0.000328	0.00125	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000328	0.00125	CcSEcCtD
Bromocriptine—ADRA2A—brain—multiple sclerosis	0.000327	0.0014	CbGeAlD
Bromocriptine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000326	0.00124	CcSEcCtD
Bromocriptine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000325	0.00124	CcSEcCtD
Bromocriptine—Shock—Prednisolone—multiple sclerosis	0.000324	0.00123	CcSEcCtD
Bromocriptine—CYP3A4—central nervous system—multiple sclerosis	0.000324	0.00138	CbGeAlD
Bromocriptine—Convulsion—Triamcinolone—multiple sclerosis	0.000322	0.00122	CcSEcCtD
Bromocriptine—Tachycardia—Prednisolone—multiple sclerosis	0.000321	0.00122	CcSEcCtD
Bromocriptine—Convulsion—Methylprednisolone—multiple sclerosis	0.000321	0.00122	CcSEcCtD
Bromocriptine—Hypertension—Triamcinolone—multiple sclerosis	0.00032	0.00122	CcSEcCtD
Bromocriptine—Hypertension—Methylprednisolone—multiple sclerosis	0.00032	0.00121	CcSEcCtD
Bromocriptine—Urticaria—Mitoxantrone—multiple sclerosis	0.000319	0.00121	CcSEcCtD
Bromocriptine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000317	0.00121	CcSEcCtD
Bromocriptine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000317	0.00121	CcSEcCtD
Bromocriptine—ABCB1—medulla oblongata—multiple sclerosis	0.000317	0.00135	CbGeAlD
Bromocriptine—Vomiting—Azathioprine—multiple sclerosis	0.000316	0.0012	CcSEcCtD
Bromocriptine—Eye disorder—Prednisone—multiple sclerosis	0.000315	0.0012	CcSEcCtD
Bromocriptine—Anxiety—Methylprednisolone—multiple sclerosis	0.000314	0.00119	CcSEcCtD
Bromocriptine—Drowsiness—Methotrexate—multiple sclerosis	0.000314	0.00119	CcSEcCtD
Bromocriptine—Rash—Azathioprine—multiple sclerosis	0.000313	0.00119	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000313	0.00119	CcSEcCtD
Bromocriptine—Dermatitis—Azathioprine—multiple sclerosis	0.000313	0.00119	CcSEcCtD
Bromocriptine—Headache—Azathioprine—multiple sclerosis	0.000311	0.00118	CcSEcCtD
Bromocriptine—Dry mouth—Triamcinolone—multiple sclerosis	0.000309	0.00117	CcSEcCtD
Bromocriptine—Angiopathy—Prednisone—multiple sclerosis	0.000306	0.00116	CcSEcCtD
Bromocriptine—Confusional state—Methylprednisolone—multiple sclerosis	0.000305	0.00116	CcSEcCtD
Bromocriptine—Oedema—Triamcinolone—multiple sclerosis	0.000303	0.00115	CcSEcCtD
Bromocriptine—Vertigo—Betamethasone—multiple sclerosis	0.000303	0.00115	CcSEcCtD
Bromocriptine—Vertigo—Dexamethasone—multiple sclerosis	0.000303	0.00115	CcSEcCtD
Bromocriptine—Syncope—Betamethasone—multiple sclerosis	0.000302	0.00115	CcSEcCtD
Bromocriptine—Syncope—Dexamethasone—multiple sclerosis	0.000302	0.00115	CcSEcCtD
Bromocriptine—Arrhythmia—Prednisone—multiple sclerosis	0.000301	0.00114	CcSEcCtD
Bromocriptine—Infection—Triamcinolone—multiple sclerosis	0.000301	0.00114	CcSEcCtD
Bromocriptine—Infection—Methylprednisolone—multiple sclerosis	0.0003	0.00114	CcSEcCtD
Bromocriptine—Shock—Triamcinolone—multiple sclerosis	0.000298	0.00113	CcSEcCtD
Bromocriptine—Insomnia—Prednisolone—multiple sclerosis	0.000298	0.00113	CcSEcCtD
Bromocriptine—Alopecia—Prednisone—multiple sclerosis	0.000298	0.00113	CcSEcCtD
Bromocriptine—Shock—Methylprednisolone—multiple sclerosis	0.000297	0.00113	CcSEcCtD
Bromocriptine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000296	0.00113	CcSEcCtD
Bromocriptine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000296	0.00112	CcSEcCtD
Bromocriptine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000296	0.00112	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisolone—multiple sclerosis	0.000296	0.00112	CcSEcCtD
Bromocriptine—Tachycardia—Triamcinolone—multiple sclerosis	0.000296	0.00112	CcSEcCtD
Bromocriptine—Mental disorder—Prednisone—multiple sclerosis	0.000295	0.00112	CcSEcCtD
Bromocriptine—Nausea—Azathioprine—multiple sclerosis	0.000295	0.00112	CcSEcCtD
Bromocriptine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000295	0.00112	CcSEcCtD
Bromocriptine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000294	0.00112	CcSEcCtD
Bromocriptine—Convulsion—Betamethasone—multiple sclerosis	0.000292	0.00111	CcSEcCtD
Bromocriptine—Convulsion—Dexamethasone—multiple sclerosis	0.000292	0.00111	CcSEcCtD
Bromocriptine—Hypertension—Betamethasone—multiple sclerosis	0.000291	0.0011	CcSEcCtD
Bromocriptine—Hypertension—Dexamethasone—multiple sclerosis	0.000291	0.0011	CcSEcCtD
Bromocriptine—ABCB1—midbrain—multiple sclerosis	0.00029	0.00124	CbGeAlD
Bromocriptine—Asthenia—Mitoxantrone—multiple sclerosis	0.000288	0.00109	CcSEcCtD
Bromocriptine—Anxiety—Dexamethasone—multiple sclerosis	0.000286	0.00109	CcSEcCtD
Bromocriptine—Anxiety—Betamethasone—multiple sclerosis	0.000286	0.00109	CcSEcCtD
Bromocriptine—ABCB1—spinal cord—multiple sclerosis	0.000283	0.00121	CbGeAlD
Bromocriptine—Hypotension—Methylprednisolone—multiple sclerosis	0.000282	0.00107	CcSEcCtD
Bromocriptine—HTR2A—brain—multiple sclerosis	0.000278	0.00119	CbGeAlD
Bromocriptine—Vision blurred—Prednisone—multiple sclerosis	0.000276	0.00105	CcSEcCtD
Bromocriptine—Oedema—Dexamethasone—multiple sclerosis	0.000275	0.00104	CcSEcCtD
Bromocriptine—Oedema—Betamethasone—multiple sclerosis	0.000275	0.00104	CcSEcCtD
Bromocriptine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000275	0.00104	CcSEcCtD
Bromocriptine—Insomnia—Triamcinolone—multiple sclerosis	0.000274	0.00104	CcSEcCtD
Bromocriptine—Insomnia—Methylprednisolone—multiple sclerosis	0.000273	0.00104	CcSEcCtD
Bromocriptine—Infection—Dexamethasone—multiple sclerosis	0.000273	0.00104	CcSEcCtD
Bromocriptine—Infection—Betamethasone—multiple sclerosis	0.000273	0.00104	CcSEcCtD
Bromocriptine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000272	0.00103	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000271	0.00103	CcSEcCtD
Bromocriptine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000271	0.00103	CcSEcCtD
Bromocriptine—Visual impairment—Methotrexate—multiple sclerosis	0.000271	0.00103	CcSEcCtD
Bromocriptine—Shock—Betamethasone—multiple sclerosis	0.00027	0.00103	CcSEcCtD
Bromocriptine—Shock—Dexamethasone—multiple sclerosis	0.00027	0.00103	CcSEcCtD
Bromocriptine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00027	0.00103	CcSEcCtD
Bromocriptine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00027	0.00102	CcSEcCtD
Bromocriptine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00027	0.00102	CcSEcCtD
Bromocriptine—Agitation—Prednisone—multiple sclerosis	0.000269	0.00102	CcSEcCtD
Bromocriptine—Tachycardia—Betamethasone—multiple sclerosis	0.000268	0.00102	CcSEcCtD
Bromocriptine—Tachycardia—Dexamethasone—multiple sclerosis	0.000268	0.00102	CcSEcCtD
Bromocriptine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000267	0.00101	CcSEcCtD
Bromocriptine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000266	0.00101	CcSEcCtD
Bromocriptine—Vertigo—Prednisone—multiple sclerosis	0.000263	0.001	CcSEcCtD
Bromocriptine—Eye disorder—Methotrexate—multiple sclerosis	0.000263	0.001	CcSEcCtD
Bromocriptine—Syncope—Prednisone—multiple sclerosis	0.000263	0.000999	CcSEcCtD
Bromocriptine—Tinnitus—Methotrexate—multiple sclerosis	0.000262	0.000998	CcSEcCtD
Bromocriptine—Anorexia—Dexamethasone—multiple sclerosis	0.000262	0.000996	CcSEcCtD
Bromocriptine—Anorexia—Betamethasone—multiple sclerosis	0.000262	0.000996	CcSEcCtD
Bromocriptine—Urticaria—Prednisolone—multiple sclerosis	0.000262	0.000994	CcSEcCtD
Bromocriptine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000261	0.000993	CcSEcCtD
Bromocriptine—Fatigue—Triamcinolone—multiple sclerosis	0.000261	0.000992	CcSEcCtD
Bromocriptine—Fatigue—Methylprednisolone—multiple sclerosis	0.000261	0.00099	CcSEcCtD
Bromocriptine—Loss of consciousness—Prednisone—multiple sclerosis	0.000258	0.00098	CcSEcCtD
Bromocriptine—Hypotension—Betamethasone—multiple sclerosis	0.000257	0.000976	CcSEcCtD
Bromocriptine—Hypotension—Dexamethasone—multiple sclerosis	0.000257	0.000976	CcSEcCtD
Bromocriptine—Angiopathy—Methotrexate—multiple sclerosis	0.000255	0.000971	CcSEcCtD
Bromocriptine—Vomiting—Mitoxantrone—multiple sclerosis	0.000255	0.00097	CcSEcCtD
Bromocriptine—Convulsion—Prednisone—multiple sclerosis	0.000254	0.000966	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000254	0.000964	CcSEcCtD
Bromocriptine—Hypertension—Prednisone—multiple sclerosis	0.000253	0.000962	CcSEcCtD
Bromocriptine—Rash—Mitoxantrone—multiple sclerosis	0.000253	0.000962	CcSEcCtD
Bromocriptine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000253	0.000961	CcSEcCtD
Bromocriptine—Headache—Mitoxantrone—multiple sclerosis	0.000251	0.000956	CcSEcCtD
Bromocriptine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00025	0.000949	CcSEcCtD
Bromocriptine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000249	0.000946	CcSEcCtD
Bromocriptine—Anxiety—Prednisone—multiple sclerosis	0.000249	0.000946	CcSEcCtD
Bromocriptine—Alopecia—Methotrexate—multiple sclerosis	0.000249	0.000945	CcSEcCtD
Bromocriptine—Insomnia—Betamethasone—multiple sclerosis	0.000249	0.000945	CcSEcCtD
Bromocriptine—Insomnia—Dexamethasone—multiple sclerosis	0.000249	0.000945	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000248	0.000942	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000247	0.000939	CcSEcCtD
Bromocriptine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000247	0.000938	CcSEcCtD
Bromocriptine—Paraesthesia—Betamethasone—multiple sclerosis	0.000247	0.000938	CcSEcCtD
Bromocriptine—Mental disorder—Methotrexate—multiple sclerosis	0.000247	0.000937	CcSEcCtD
Bromocriptine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000242	0.000919	CcSEcCtD
Bromocriptine—Dyspepsia—Betamethasone—multiple sclerosis	0.000242	0.000919	CcSEcCtD
Bromocriptine—Urticaria—Triamcinolone—multiple sclerosis	0.000241	0.000914	CcSEcCtD
Bromocriptine—Urticaria—Methylprednisolone—multiple sclerosis	0.00024	0.000912	CcSEcCtD
Bromocriptine—Dysgeusia—Methotrexate—multiple sclerosis	0.00024	0.000912	CcSEcCtD
Bromocriptine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000239	0.00091	CcSEcCtD
Bromocriptine—Oedema—Prednisone—multiple sclerosis	0.000239	0.00091	CcSEcCtD
Bromocriptine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000239	0.000908	CcSEcCtD
Bromocriptine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000239	0.000908	CcSEcCtD
Bromocriptine—Decreased appetite—Betamethasone—multiple sclerosis	0.000239	0.000908	CcSEcCtD
Bromocriptine—Nausea—Mitoxantrone—multiple sclerosis	0.000238	0.000906	CcSEcCtD
Bromocriptine—ABCB1—nervous system—multiple sclerosis	0.000238	0.00102	CbGeAlD
Bromocriptine—Infection—Prednisone—multiple sclerosis	0.000238	0.000904	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000237	0.000902	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000237	0.000902	CcSEcCtD
Bromocriptine—Fatigue—Betamethasone—multiple sclerosis	0.000237	0.0009	CcSEcCtD
Bromocriptine—Fatigue—Dexamethasone—multiple sclerosis	0.000237	0.0009	CcSEcCtD
Bromocriptine—Shock—Prednisone—multiple sclerosis	0.000235	0.000895	CcSEcCtD
Bromocriptine—Nervous system disorder—Prednisone—multiple sclerosis	0.000235	0.000892	CcSEcCtD
Bromocriptine—Tachycardia—Prednisone—multiple sclerosis	0.000234	0.000888	CcSEcCtD
Bromocriptine—Skin disorder—Prednisone—multiple sclerosis	0.000232	0.000883	CcSEcCtD
Bromocriptine—Vision blurred—Methotrexate—multiple sclerosis	0.000231	0.000878	CcSEcCtD
Bromocriptine—ABCB1—central nervous system—multiple sclerosis	0.000229	0.00098	CbGeAlD
Bromocriptine—Anorexia—Prednisone—multiple sclerosis	0.000228	0.000867	CcSEcCtD
Bromocriptine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000226	0.000861	CcSEcCtD
Bromocriptine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000226	0.000861	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000225	0.000854	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000225	0.000854	CcSEcCtD
Bromocriptine—ABCB1—cerebellum—multiple sclerosis	0.000224	0.000958	CbGeAlD
Bromocriptine—Vertigo—Methotrexate—multiple sclerosis	0.00022	0.000837	CcSEcCtD
Bromocriptine—Urticaria—Betamethasone—multiple sclerosis	0.000218	0.00083	CcSEcCtD
Bromocriptine—Urticaria—Dexamethasone—multiple sclerosis	0.000218	0.00083	CcSEcCtD
Bromocriptine—Dizziness—Prednisolone—multiple sclerosis	0.000218	0.000828	CcSEcCtD
Bromocriptine—Asthenia—Triamcinolone—multiple sclerosis	0.000217	0.000826	CcSEcCtD
Bromocriptine—Abdominal pain—Betamethasone—multiple sclerosis	0.000217	0.000826	CcSEcCtD
Bromocriptine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000217	0.000826	CcSEcCtD
Bromocriptine—Body temperature increased—Betamethasone—multiple sclerosis	0.000217	0.000826	CcSEcCtD
Bromocriptine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000217	0.000826	CcSEcCtD
Bromocriptine—Asthenia—Methylprednisolone—multiple sclerosis	0.000217	0.000824	CcSEcCtD
Bromocriptine—Insomnia—Prednisone—multiple sclerosis	0.000216	0.000823	CcSEcCtD
Bromocriptine—Paraesthesia—Prednisone—multiple sclerosis	0.000215	0.000817	CcSEcCtD
Bromocriptine—Convulsion—Methotrexate—multiple sclerosis	0.000212	0.000807	CcSEcCtD
Bromocriptine—Dyspepsia—Prednisone—multiple sclerosis	0.000211	0.000801	CcSEcCtD
Bromocriptine—Decreased appetite—Prednisone—multiple sclerosis	0.000208	0.000791	CcSEcCtD
Bromocriptine—Rash—Prednisolone—multiple sclerosis	0.000208	0.000789	CcSEcCtD
Bromocriptine—Dermatitis—Prednisolone—multiple sclerosis	0.000207	0.000788	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000207	0.000788	CcSEcCtD
Bromocriptine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000207	0.000786	CcSEcCtD
Bromocriptine—Fatigue—Prednisone—multiple sclerosis	0.000206	0.000784	CcSEcCtD
Bromocriptine—Headache—Prednisolone—multiple sclerosis	0.000206	0.000784	CcSEcCtD
Bromocriptine—Constipation—Prednisone—multiple sclerosis	0.000205	0.000778	CcSEcCtD
Bromocriptine—Confusional state—Methotrexate—multiple sclerosis	0.000202	0.000766	CcSEcCtD
Bromocriptine—Dizziness—Triamcinolone—multiple sclerosis	0.0002	0.000761	CcSEcCtD
Bromocriptine—Dizziness—Methylprednisolone—multiple sclerosis	0.0002	0.000759	CcSEcCtD
Bromocriptine—Infection—Methotrexate—multiple sclerosis	0.000199	0.000755	CcSEcCtD
Bromocriptine—Feeling abnormal—Prednisone—multiple sclerosis	0.000197	0.00075	CcSEcCtD
Bromocriptine—Asthenia—Betamethasone—multiple sclerosis	0.000197	0.000749	CcSEcCtD
Bromocriptine—Asthenia—Dexamethasone—multiple sclerosis	0.000197	0.000749	CcSEcCtD
Bromocriptine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000196	0.000745	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000196	0.000744	CcSEcCtD
Bromocriptine—Nausea—Prednisolone—multiple sclerosis	0.000196	0.000743	CcSEcCtD
Bromocriptine—Skin disorder—Methotrexate—multiple sclerosis	0.000194	0.000738	CcSEcCtD
Bromocriptine—Vomiting—Triamcinolone—multiple sclerosis	0.000193	0.000732	CcSEcCtD
Bromocriptine—Vomiting—Methylprednisolone—multiple sclerosis	0.000192	0.00073	CcSEcCtD
Bromocriptine—Rash—Triamcinolone—multiple sclerosis	0.000191	0.000726	CcSEcCtD
Bromocriptine—Dermatitis—Triamcinolone—multiple sclerosis	0.000191	0.000725	CcSEcCtD
Bromocriptine—Anorexia—Methotrexate—multiple sclerosis	0.000191	0.000725	CcSEcCtD
Bromocriptine—Rash—Methylprednisolone—multiple sclerosis	0.000191	0.000724	CcSEcCtD
Bromocriptine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00019	0.000723	CcSEcCtD
Bromocriptine—Urticaria—Prednisone—multiple sclerosis	0.00019	0.000723	CcSEcCtD
Bromocriptine—Headache—Triamcinolone—multiple sclerosis	0.00019	0.000721	CcSEcCtD
Bromocriptine—Headache—Methylprednisolone—multiple sclerosis	0.000189	0.00072	CcSEcCtD
Bromocriptine—Abdominal pain—Prednisone—multiple sclerosis	0.000189	0.000719	CcSEcCtD
Bromocriptine—Body temperature increased—Prednisone—multiple sclerosis	0.000189	0.000719	CcSEcCtD
Bromocriptine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000188	0.000715	CcSEcCtD
Bromocriptine—Diarrhoea—Betamethasone—multiple sclerosis	0.000188	0.000715	CcSEcCtD
Bromocriptine—Hypotension—Methotrexate—multiple sclerosis	0.000187	0.00071	CcSEcCtD
Bromocriptine—ABCB1—brain—multiple sclerosis	0.000182	0.000778	CbGeAlD
Bromocriptine—Dizziness—Dexamethasone—multiple sclerosis	0.000182	0.000691	CcSEcCtD
Bromocriptine—Dizziness—Betamethasone—multiple sclerosis	0.000182	0.000691	CcSEcCtD
Bromocriptine—Insomnia—Methotrexate—multiple sclerosis	0.000181	0.000688	CcSEcCtD
Bromocriptine—Nausea—Triamcinolone—multiple sclerosis	0.00018	0.000684	CcSEcCtD
Bromocriptine—Paraesthesia—Methotrexate—multiple sclerosis	0.00018	0.000683	CcSEcCtD
Bromocriptine—Nausea—Methylprednisolone—multiple sclerosis	0.00018	0.000682	CcSEcCtD
Bromocriptine—Dyspnoea—Methotrexate—multiple sclerosis	0.000178	0.000678	CcSEcCtD
Bromocriptine—Somnolence—Methotrexate—multiple sclerosis	0.000178	0.000676	CcSEcCtD
Bromocriptine—Dyspepsia—Methotrexate—multiple sclerosis	0.000176	0.000669	CcSEcCtD
Bromocriptine—Vomiting—Dexamethasone—multiple sclerosis	0.000175	0.000664	CcSEcCtD
Bromocriptine—Vomiting—Betamethasone—multiple sclerosis	0.000175	0.000664	CcSEcCtD
Bromocriptine—Decreased appetite—Methotrexate—multiple sclerosis	0.000174	0.000661	CcSEcCtD
Bromocriptine—Rash—Dexamethasone—multiple sclerosis	0.000173	0.000659	CcSEcCtD
Bromocriptine—Rash—Betamethasone—multiple sclerosis	0.000173	0.000659	CcSEcCtD
Bromocriptine—Dermatitis—Betamethasone—multiple sclerosis	0.000173	0.000658	CcSEcCtD
Bromocriptine—Dermatitis—Dexamethasone—multiple sclerosis	0.000173	0.000658	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000173	0.000656	CcSEcCtD
Bromocriptine—Fatigue—Methotrexate—multiple sclerosis	0.000172	0.000655	CcSEcCtD
Bromocriptine—Headache—Betamethasone—multiple sclerosis	0.000172	0.000654	CcSEcCtD
Bromocriptine—Headache—Dexamethasone—multiple sclerosis	0.000172	0.000654	CcSEcCtD
Bromocriptine—Asthenia—Prednisone—multiple sclerosis	0.000172	0.000653	CcSEcCtD
Bromocriptine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000165	0.000626	CcSEcCtD
Bromocriptine—Diarrhoea—Prednisone—multiple sclerosis	0.000164	0.000622	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000164	0.000622	CcSEcCtD
Bromocriptine—Nausea—Dexamethasone—multiple sclerosis	0.000163	0.00062	CcSEcCtD
Bromocriptine—Nausea—Betamethasone—multiple sclerosis	0.000163	0.00062	CcSEcCtD
Bromocriptine—Urticaria—Methotrexate—multiple sclerosis	0.000159	0.000604	CcSEcCtD
Bromocriptine—Dizziness—Prednisone—multiple sclerosis	0.000158	0.000601	CcSEcCtD
Bromocriptine—Abdominal pain—Methotrexate—multiple sclerosis	0.000158	0.000601	CcSEcCtD
Bromocriptine—Body temperature increased—Methotrexate—multiple sclerosis	0.000158	0.000601	CcSEcCtD
Bromocriptine—Vomiting—Prednisone—multiple sclerosis	0.000152	0.000578	CcSEcCtD
Bromocriptine—Rash—Prednisone—multiple sclerosis	0.000151	0.000574	CcSEcCtD
Bromocriptine—Dermatitis—Prednisone—multiple sclerosis	0.000151	0.000573	CcSEcCtD
Bromocriptine—Headache—Prednisone—multiple sclerosis	0.00015	0.00057	CcSEcCtD
Bromocriptine—Asthenia—Methotrexate—multiple sclerosis	0.000144	0.000545	CcSEcCtD
Bromocriptine—Nausea—Prednisone—multiple sclerosis	0.000142	0.00054	CcSEcCtD
Bromocriptine—Diarrhoea—Methotrexate—multiple sclerosis	0.000137	0.00052	CcSEcCtD
Bromocriptine—Dizziness—Methotrexate—multiple sclerosis	0.000132	0.000503	CcSEcCtD
Bromocriptine—Vomiting—Methotrexate—multiple sclerosis	0.000127	0.000483	CcSEcCtD
Bromocriptine—Rash—Methotrexate—multiple sclerosis	0.000126	0.000479	CcSEcCtD
Bromocriptine—Dermatitis—Methotrexate—multiple sclerosis	0.000126	0.000479	CcSEcCtD
Bromocriptine—Headache—Methotrexate—multiple sclerosis	0.000125	0.000476	CcSEcCtD
Bromocriptine—Nausea—Methotrexate—multiple sclerosis	0.000119	0.000452	CcSEcCtD
Bromocriptine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.35e-05	6.83e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	1.34e-05	6.81e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	1.34e-05	6.81e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	1.34e-05	6.78e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.33e-05	6.78e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.33e-05	6.76e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CD80—multiple sclerosis	1.33e-05	6.73e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.32e-05	6.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.32e-05	6.72e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	1.32e-05	6.72e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	1.32e-05	6.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—APOE—multiple sclerosis	1.32e-05	6.7e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.31e-05	6.67e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.31e-05	6.67e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—STAT3—multiple sclerosis	1.31e-05	6.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.31e-05	6.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	1.3e-05	6.62e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.3e-05	6.62e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	1.29e-05	6.53e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.28e-05	6.5e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	1.28e-05	6.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—ALB—multiple sclerosis	1.27e-05	6.46e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.27e-05	6.44e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.26e-05	6.41e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—POMC—multiple sclerosis	1.26e-05	6.4e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.25e-05	6.34e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.25e-05	6.33e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	1.25e-05	6.32e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	1.23e-05	6.26e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.23e-05	6.25e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	1.23e-05	6.24e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	1.23e-05	6.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.23e-05	6.23e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.22e-05	6.2e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MYC—multiple sclerosis	1.22e-05	6.19e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TGFB1—multiple sclerosis	1.22e-05	6.18e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.21e-05	6.15e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.21e-05	6.15e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.21e-05	6.14e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	1.21e-05	6.13e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	1.21e-05	6.12e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.21e-05	6.12e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL2—multiple sclerosis	1.2e-05	6.11e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL2—multiple sclerosis	1.2e-05	6.1e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.2e-05	6.09e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	1.2e-05	6.08e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—IL6—multiple sclerosis	1.2e-05	6.07e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.2e-05	6.07e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL2—multiple sclerosis	1.19e-05	6.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.19e-05	6.06e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MAPK1—multiple sclerosis	1.19e-05	6.06e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	1.19e-05	6.03e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	1.19e-05	6.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.19e-05	6.02e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.18e-05	5.99e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.17e-05	5.96e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL2—multiple sclerosis	1.17e-05	5.94e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.17e-05	5.92e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	1.16e-05	5.91e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.15e-05	5.86e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL2—multiple sclerosis	1.15e-05	5.84e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.15e-05	5.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	1.15e-05	5.83e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—IL6—multiple sclerosis	1.15e-05	5.81e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	1.14e-05	5.79e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	1.14e-05	5.78e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MMP9—multiple sclerosis	1.14e-05	5.78e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.13e-05	5.75e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	1.13e-05	5.74e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	1.12e-05	5.7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	1.12e-05	5.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.12e-05	5.67e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.11e-05	5.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	1.11e-05	5.63e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	1.11e-05	5.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.1e-05	5.6e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.1e-05	5.58e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	1.1e-05	5.58e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.1e-05	5.56e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	1.09e-05	5.55e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MMP9—multiple sclerosis	1.09e-05	5.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	1.07e-05	5.45e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.07e-05	5.44e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.07e-05	5.41e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.06e-05	5.37e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.04e-05	5.29e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.04e-05	5.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.04e-05	5.26e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL2—multiple sclerosis	1.04e-05	5.26e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.04e-05	5.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.03e-05	5.24e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	1.03e-05	5.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	5.19e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	5.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	1.02e-05	5.18e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	1.02e-05	5.18e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.02e-05	5.17e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	1.02e-05	5.16e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.02e-05	5.16e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.01e-05	5.14e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	1.01e-05	5.14e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—STAT3—multiple sclerosis	1.01e-05	5.14e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	1.01e-05	5.1e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	9.98e-06	5.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	9.97e-06	5.06e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.97e-06	5.06e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	9.84e-06	5e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	9.81e-06	4.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	9.76e-06	4.96e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—STAT3—multiple sclerosis	9.69e-06	4.92e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	9.68e-06	4.91e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	9.68e-06	4.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	9.47e-06	4.81e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MYC—multiple sclerosis	9.41e-06	4.78e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	9.4e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MYC—multiple sclerosis	9.4e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	9.39e-06	4.77e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	9.38e-06	4.76e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MYC—multiple sclerosis	9.34e-06	4.74e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.34e-06	4.74e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	9.32e-06	4.73e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL2—multiple sclerosis	9.32e-06	4.73e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	9.27e-06	4.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	9.27e-06	4.71e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	9.25e-06	4.7e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	9.25e-06	4.69e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	9.23e-06	4.69e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	9.21e-06	4.67e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	9.2e-06	4.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	9.19e-06	4.66e-05	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—IL6—multiple sclerosis	9.17e-06	4.65e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MYC—multiple sclerosis	9.15e-06	4.64e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	9.14e-06	4.64e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	9.13e-06	4.63e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—APOE—multiple sclerosis	9.12e-06	4.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.07e-06	4.6e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	9.06e-06	4.6e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MYC—multiple sclerosis	9e-06	4.57e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	8.98e-06	4.56e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	8.95e-06	4.54e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	8.91e-06	4.52e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	8.87e-06	4.5e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	8.87e-06	4.5e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	8.82e-06	4.48e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	8.82e-06	4.48e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	8.81e-06	4.47e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	8.74e-06	4.44e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	8.72e-06	4.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	8.62e-06	4.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	8.6e-06	4.37e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	8.6e-06	4.37e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	8.59e-06	4.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	8.58e-06	4.36e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	8.57e-06	4.35e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	8.49e-06	4.31e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	8.44e-06	4.29e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	8.43e-06	4.28e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	8.42e-06	4.27e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	8.41e-06	4.27e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	8.39e-06	4.26e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	8.16e-06	4.14e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—multiple sclerosis	8.1e-06	4.11e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	8.08e-06	4.1e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	8.03e-06	4.08e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—multiple sclerosis	8e-06	4.06e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	8e-06	4.06e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	7.98e-06	4.05e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	7.98e-06	4.05e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	7.93e-06	4.02e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	7.84e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—POMC—multiple sclerosis	7.84e-06	3.98e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—multiple sclerosis	7.82e-06	3.97e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	7.82e-06	3.97e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	7.82e-06	3.97e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	7.79e-06	3.95e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	7.77e-06	3.94e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	7.7e-06	3.91e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	7.66e-06	3.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	7.54e-06	3.83e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	7.5e-06	3.81e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	7.5e-06	3.81e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	7.46e-06	3.79e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	7.41e-06	3.76e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	7.29e-06	3.7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—multiple sclerosis	7.29e-06	3.7e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—APOE—multiple sclerosis	7.28e-06	3.7e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	7.27e-06	3.69e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	7.26e-06	3.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	7.22e-06	3.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	7.2e-06	3.66e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—multiple sclerosis	7.14e-06	3.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	7.14e-06	3.63e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	7.13e-06	3.62e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	7.13e-06	3.62e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—multiple sclerosis	7.08e-06	3.59e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—multiple sclerosis	7.07e-06	3.59e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	7.06e-06	3.58e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—multiple sclerosis	7.02e-06	3.56e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	7e-06	3.56e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	6.97e-06	3.54e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	6.97e-06	3.54e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	6.95e-06	3.53e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	6.93e-06	3.52e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	6.92e-06	3.51e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—multiple sclerosis	6.88e-06	3.49e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	6.82e-06	3.46e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	6.78e-06	3.44e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—multiple sclerosis	6.77e-06	3.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	6.74e-06	3.42e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	6.73e-06	3.41e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	6.64e-06	3.37e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	6.63e-06	3.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	6.62e-06	3.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	6.6e-06	3.35e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	6.58e-06	3.34e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	6.49e-06	3.3e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	6.48e-06	3.29e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	6.46e-06	3.28e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	6.34e-06	3.22e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—POMC—multiple sclerosis	6.26e-06	3.18e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—multiple sclerosis	6.12e-06	3.11e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	6.1e-06	3.1e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—multiple sclerosis	6.09e-06	3.09e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	6.02e-06	3.06e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	6.01e-06	3.05e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—multiple sclerosis	6.01e-06	3.05e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	6.01e-06	3.05e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	5.99e-06	3.04e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	5.89e-06	2.99e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	5.89e-06	2.99e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	5.89e-06	2.99e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	5.88e-06	2.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	5.77e-06	2.93e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—multiple sclerosis	5.7e-06	2.89e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—APOE—multiple sclerosis	5.62e-06	2.85e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	5.48e-06	2.78e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—multiple sclerosis	5.48e-06	2.78e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	5.46e-06	2.77e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	5.43e-06	2.75e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	5.36e-06	2.72e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	5.24e-06	2.66e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	5.21e-06	2.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	5.07e-06	2.57e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	4.99e-06	2.53e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—POMC—multiple sclerosis	4.83e-06	2.45e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—multiple sclerosis	4.6e-06	2.33e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	4.53e-06	2.3e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	4.43e-06	2.25e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—multiple sclerosis	4.4e-06	2.23e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	4.12e-06	2.09e-05	CbGpPWpGaD
